Daniel Reeves

33PUBLICATIONS
135CO-AUTHORS
Nanotoxicology, health and safetyHost-parasite interactionsMedical molecular engineering of nucleic acids and proteinsPharmaceutical delivery technologiesGenetic immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (33)

|Sep 28, 2026
Prophylactic treatment with broadly neutralizing antibody VRC01 selects for escape mutants after infection in Antibody-Mediated Prevention trials.

|Sep 24, 2026
Transmission of mutated SARS-CoV-2 variants is favored by relatively prolonged infections due to delayed immunity.

|Jun 29, 2026
Modeling quantifies in vivo neutralization, Fc-mediated killing, and resistance in human clinical trials of five anti-HIV broadly neutralizing antibodies.

|Apr 17, 2026
Clinical trial simulation of antiviral drugs.

|Apr 03, 2026
Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials.

Carolyn Williamson, Chivonne Moodley, Craig A Magaret

|Feb 20, 2026
Q4ddPCR: a flexible, 4-target assay for high-resolution HIV reservoir profiling.

Rachel Scheck, Mark Melzer, Gregory Gladkov

Pageof 6

Frequent Collaborators

14 joint publications

Joshua T Schiffer

6 joint publications

Yunda Huang

6 joint publications

Bryan T Mayer

6 joint publications

Paul T Edlefsen